Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study (vol 70, pg 526, 2009)

被引：0
|
作者：
Cutler, Andrew J.
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2009年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1729 / 1729
页数：1
相关论文
共 50 条
  • [41] Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
    Detke, MJ
    Wiltse, CG
    Mallinckrodt, CH
    McNamara, RK
    Demitrack, MA
    Bitter, I
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (06) : 457 - 470
  • [42] COST EFFECTIVENESS OF EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) MONOTHERAPY IN TURKEY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) WHO HAVE FAILED PREVIOUS ANTIDEPRESSANT THERAPY
    Aydemir, O.
    Dilbaz, N.
    Malhan, S.
    VALUE IN HEALTH, 2011, 14 (07) : A291 - A292
  • [43] Sustained response with adjunctive extended release Quetiapine Fumarate (Quetiapine XR): pooled efficacy analysis in Major Depressive Disorder (MDD)
    Bauer, M.
    Vieta, E.
    Earley, W.
    Szamosi, J.
    Eriksson, H. A.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 24 - 24
  • [44] Quetiapine monotherapy in acute phase for major depressive disorder: a metaanalysis of randomized, placebo-controlled trials
    Maneeton, N.
    Maneeton, B.
    Srisurapanont, M.
    Martin, S. D.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [45] Once-daily extended-release Quetiapine Fumarate (Quetiapine XR) monotherapy in generalised anxiety disorder (GAD): A placebo-controlled study with active-comparator Patoxetine
    Chouinard, G.
    Bobes, J.
    Ahokas, A.
    Eggens, I.
    Liu, S.
    Brecher, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S211 - S211
  • [46] Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies
    Weisler, Richard
    Montgomery, Stuart A.
    Earley, Willie R.
    Szamosi, Johan
    Eriksson, Hans
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : 520 - U258
  • [47] Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies
    Trivedi, Madhukar H.
    Bandelow, Borwin
    Demyttenaere, Koen
    Papakosts, George I.
    Szamosi, Johan
    Earley, Willie
    Eriksson, Hans
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (08): : 1733 - 1744
  • [48] A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder
    Zhao, Qian
    Fu, Bingbing
    Lyu, Nan
    Xu, Xiangdong
    Huang, Guangbiao
    Tan, Yunlong
    Xu, Xiufeng
    Zhang, Xuehua
    Wang, Xueyi
    Wang, Zhiqiang
    Li, Keqing
    Hu, ZhenYu
    Li, Hengfen
    He, Hongbo
    Li, Shuang
    Zhao, Jingyuan
    He, Ruifeng
    Guo, Hua
    Li, Yi
    Li, Lehua
    Yang, Chuang
    Zou, Shaohong
    Wei, Bo
    Wang, Wenqiang
    Chen, Ce
    Lu, Zheng
    He, Shunqiang
    Wang, Qian
    Zhao, Jinghua
    Pan, Xiaoyue
    Pan, Zhenyu
    Li, Junqing
    Wang, Gang
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 329 : 72 - 80
  • [49] Results from a phase III study of extended release quetiapine fumarate (quetiapine XR) as add-on to antidepressants in patients with major depressive disorder (MDD)
    Bauer, M.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 315 - 316
  • [50] Effect of once-daily extended release Quetiapine Fumarate (Quetiapine XR) as add-on to antidepressants in major depressive disorder (MDD)
    Bauer, M.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S243 - S243
12345